Trials / Completed
CompletedNCT01215370
Pea Protein and Postprandial Response (PEA)
Effect of Arginine-rich Dietary Protein on Postprandial Metabolism, Inflammation and Endothelial Function
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Wageningen University · Academic / Other
- Sex
- Male
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The main objective is to investigate the postprandial effect of arginine-rich protein (i.e. pea-protein) on metabolic control, inflammation and endothelial function after a high-fat meal in subjects with characteristics of the metabolic syndrome.
Detailed description
Arginine is potential interesting considering the metabolic syndrome. Studies so far indicated both long-term effects, as well as acute - postprandial - actions; especially when metabolism is already challenged, e.g. in diabetic patients or after a high-fat meal. If arginine-rich proteins are equally effective is not known. Therefore we are interested in the effect of (arginine rich) protein on postprandial (dys)metabolism, inflammation and endothelial function, within 6 hours after a meal.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | High-fat shake with Pea protein | Shake containing 95 gram of fat, additive 30 gram pea protein |
| OTHER | High-fat shake with Pea protein hydrolysate | Shake containing 95 gram of fat, additive 30 gram gluten protein hydrolysate |
| OTHER | High-fat shake - Control | Shake containing 95 gram of fat, no protein additive |
| OTHER | High-fat shake with Gluten protein | Shake containing 95 gram of fat, additive 30 gram gluten protein. |
| OTHER | High-fat shake with Gluten protein hydrolysate | Shake containing 95 gram of fat, additive 30 gram gluten gluten hydrolysate |
Timeline
- Start date
- 2010-09-01
- Primary completion
- 2011-01-01
- Completion
- 2011-01-01
- First posted
- 2010-10-06
- Last updated
- 2011-09-07
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01215370. Inclusion in this directory is not an endorsement.